Detalhe da pesquisa
1.
Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study.
Br J Dermatol
; 189(4): 392-399, 2023 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37279795
2.
Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials.
JAMA
; 328(11): 1073-1084, 2022 09 20.
Artigo
Inglês
| MEDLINE | ID: mdl-36125472
3.
Efficacy and safety of roflumilast cream for chronic plaque psoriasis with facial/neck and intertriginous area involvement: a post hoc analysis from a randomized controlled trial.
Br J Dermatol
; 188(6): 810-812, 2023 05 24.
Artigo
Inglês
| MEDLINE | ID: mdl-36890712
4.
Pharmacokinetics of Roflumilast Cream in Chronic Plaque Psoriasis: Data from Phase I to Phase III Studies.
Am J Clin Dermatol
; 24(2): 315-324, 2023 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-36422852
5.
Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b Trial.
Am J Clin Dermatol
; 24(2): 305-313, 2023 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-36370336
6.
Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial.
JAMA Dermatol
; 159(6): 613-620, 2023 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37133856
7.
The Proposed PASI-HD Provides More Precise Assessment of Plaque Psoriasis Severity in Anatomical Regions with a Low Area Score.
Dermatol Ther (Heidelb)
; 11(4): 1079-1083, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-34236691